Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Is long-term survival of liver transplant recipients improved by mycophenolate mofetil combination therapy?

Nature Clinical Practice Gastroenterology & Hepatology volume 3, pages 132–133 (2006)Cite this article

boxed-textWiesner RH et al. Mycophenolate mofetil combination therapy improves long-term outcomes after liver transplantation in patients with and without hepatitis C. Liver Transplant 11: 750–759

Combination immunosuppression therapy with mycophenolate mofetil seems to improve long-term outcomes in liver transplant recipients, but these observations need to be validated and ideal regimens defined

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Platz KP et al. (1994) Nephrotoxicity following orthotopic liver-transplantation—a comparison between ciclosporin and fk506. Transplantation 58: 170–178

    Article  CAS  Google Scholar 

  2. Allison AC and Euguir EM (2000) Mycophenolate mofetil and its mechanisms of action. Immunopharmacology 47: 85–118

    Article  CAS  Google Scholar 

  3. Bahra M et al. (2005) MMF and calcineurin taper in recurrent hepatitis C after liver transplantation: impact on histologic course. Am J Transplant 5: 406–411

    Article  CAS  Google Scholar 

  4. Eckhoff DE et al. (1998) Tacrolimus (FK506) and mycophenolate mofetil combination therapy versus tacrolimus in adult liver transplantation. Transplantation 65: 180–187

    Article  CAS  Google Scholar 

  5. Schlitt HJ et al. (2001) Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction: a randomised controlled study. Lancet 357: 587–591

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Rachel Jones, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Clinical Research Assistant,

    Elliott D Kozin & K Rajender Reddy

  2. Professor of Medicine and Surgery, Director of Hepatology, and Medical Director of Liver Transplantation, at the Hospital of the University of Pennsylvania, PA, USA

    Elliott D Kozin & K Rajender Reddy

Authors
  1. Elliott D Kozin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K Rajender Reddy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to K Rajender Reddy.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kozin, E., Reddy, K. Is long-term survival of liver transplant recipients improved by mycophenolate mofetil combination therapy?. Nat Rev Gastroenterol Hepatol 3, 132–133 (2006). https://doi.org/10.1038/ncpgasthep0439

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpgasthep0439

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing